MIKROBE Management of Infected Knee Replacements-Obtaining Best Evidence
MIKROBE
1 other identifier
interventional
3
1 country
2
Brief Summary
Following a prosthetic knee joint infection, two types of operative approach can be undertaken to treat the infection: a one-stage or two-stage revision operation. Both approaches are widely used and are good at treating infection but we don't know which has the best long-term outcomes for patients. This trial aims to assess the feasibility of conducting a randomised controlled trial to evaluate whether treating a prosthetic knee infection with one-stage revision surgery gives a better outcome than two-stage revision surgery in terms of patient function and pain, and cost-effectiveness.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2020
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 5, 2020
CompletedFirst Posted
Study publicly available on registry
July 7, 2020
CompletedStudy Start
First participant enrolled
November 17, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
January 30, 2023
CompletedNovember 18, 2023
November 1, 2023
2.2 years
June 5, 2020
November 15, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Ease of recruitment of participants
Number of recruits compared to the number of potential participants.
20 months
Secondary Outcomes (10)
Explaining the study
20 months
Reasons for non-participation
20 months
Patient experience
2 weeks after surgery
Surgeon experience
20 months
Protocol adherence
20 months
- +5 more secondary outcomes
Study Arms (2)
One-stage
ACTIVE COMPARATORTwo-stage
ACTIVE COMPARATORInterventions
A one-stage revision operation involves one operation to remove the joint, thoroughly cleaning the infected area and then implanting a new joint immediately.
A two-stage revision operation involves two operations: the joint is removed in one operation, a temporary spacer device is inserted, then the infection is treated with antibiotics, and then a new joint is implanted in a second operation.
Eligibility Criteria
You may qualify if:
- Adults with prosthetic knee infection suitable for either one-stage or two-stage revision surgery
- Intra-operatively, all cases must have adequate soft-tissue coverage post debridement to allow single or two stage revision surgery.
- Case meets the International Consensus Meeting criteria for infection
- Patients having had a Debridement, Anti-biotic and Implant Retained procedure previously or washout/biopsy only of an infected TKR are suitable
You may not qualify if:
- Unable or unwilling to undergo either treatment
- Lacking capacity to consent to research
- Refusal to consent to study for any reason
- Re-revision of prosthetic knee infection if first revision was for infection
- Presence of tuberculosis infection
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Royal Devon and Exeter NHS Foundation Trustlead
- University of Exetercollaborator
- Nuffield Orthopaedic Centre NHS Trustcollaborator
- Nottingham University Hospitals NHS Trustcollaborator
- Wrightington, Wigan and Leigh NHS Foundation Trustcollaborator
Study Sites (2)
Princess Elizabeth Orthopaedic Centre, Royal Devon and Exeter NHS Trust (RD&E NHSFT)
Exeter, Devon, EX2 5DW, United Kingdom
Nuffiels Orthopaedic Centre (NOC)
Oxford, United Kingdom
Related Publications (1)
Terry R, Dean S, Hourigan P, Waterson HB, Wylde V, Carpenter N, Whale B, Powell RJ, Tarrant P, Medina-Lara A, Alvand A, Toms AD. MIKROBE: a feasibility study for a randomised controlled trial of one-stage or two-stage surgery for prosthetic knee infection. Pilot Feasibility Stud. 2025 Apr 16;11(1):49. doi: 10.1186/s40814-025-01634-4.
PMID: 40241215DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Andrew Toms, FRCS
Royal Devon and Exeter NHS Foundation Trust
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- Blinding of participants and trial personnel will not be possible due to the nature of the intervention
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 5, 2020
First Posted
July 7, 2020
Study Start
November 17, 2020
Primary Completion
January 30, 2023
Study Completion
January 30, 2023
Last Updated
November 18, 2023
Record last verified: 2023-11